Chapter

HIV-1 gp120

Shu-ichi Okamoto, Marcus Kaul, Ian Paul Everall, Eliezer Masliah and Stuart A. Lipton

in The Neurology of AIDS

Third edition

Published on behalf of Oxford University Press

Published in print December 2011 | ISBN: 9780195399349
Published online September 2012 | e-ISBN: 9780199965199 | DOI: http://dx.doi.org/10.1093/med/9780195399349.003.0020
HIV-1 gp120

More Like This

Show all results sharing these subjects:

  • Disorders of the Nervous System
  • Infectious Diseases

GO

Show Summary Details

Preview

This chapter reviews the neurotoxic effects of gp120, which has been implicated in the development of neurocognitive disorders. The toxic effects of Tat, which are discussed in detail in the Chapter by Li and Nath, are also briefly discussed. The major toxic action of gp120 is thought to be indirect, acting via NMDA receptors and other pathways, including GSK3 and the production of cytokines such as TNF- , IL-1?? and IL-6. Therapeutic strategies designed to interfere with these neurotoxic pathways and prevent or reduce harm from gp120 are considered, as are other substances, such as Tat. Agents considered include NMDA receptor antagonists, antioxidants, chemokine and cytokine antagonists, neurotrophic factors, inhibitors of GSK3 and of caspase, estrogen, and p38 MAPK antagonists.

Chapter.  12244 words.  Illustrated.

Subjects: Disorders of the Nervous System ; Infectious Diseases

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.